62 related articles for article (PubMed ID: 28855930)
21. Immunohistochemical Expression of Cell Proliferating Nuclear Antigen (PCNA) and p53 Protein in Cervical Cancer.
Madhumati G; Kavita S; Anju M; Uma S; Raj M
J Obstet Gynaecol India; 2012 Oct; 62(5):557-61. PubMed ID: 24082558
[TBL] [Abstract][Full Text] [Related]
22. HPV types in Turkey: multicenter hospital based evaluation of 6388 patients in Turkish gynecologic oncology group centers.
Dursun P; Ayhan A; Mutlu L; Çağlar M; Haberal A; Güngör T; Özat M; Özgü E; Onan A; Taşkiran C; Güner H; Yetımalar H; Kasap B; Yüce K; Salman MC; Sayal B; Doğan S; Harma M; Harma M; Basaran M; Aydoğmuş H; Ergün Y; Şehıralı S; Gültekın E; Köse S; Yildirim Y; Yenen M; Dede M; Alanbay I; Karaca R; Metındır J; Keskın L; Üstüner I; Avşar F; Yüksel H; Kirdar S
Turk Patoloji Derg; 2013; 29(3):210-6. PubMed ID: 24022311
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus genotypes distribution in 175 invasive cervical cancer cases from Brazil.
de Oliveira CM; Fregnani JH; Carvalho JP; Longatto-Filho A; Levi JE
BMC Cancer; 2013 Jul; 13():357. PubMed ID: 23883423
[TBL] [Abstract][Full Text] [Related]
24. p16(INK4a) immunohistochemistry is a promising biomarker to predict the outcome of low grade cervical intraepithelial neoplasia: comparison study with HPV genotyping.
Nishio S; Fujii T; Nishio H; Kameyama K; Saito M; Iwata T; Kubushiro K; Aoki D
J Gynecol Oncol; 2013 Jul; 24(3):215-21. PubMed ID: 23875070
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of cervical infection with HPV type 16 and 18 in Vietnam: implications for vaccine campaign.
Vu LT; Bui D; Le HT
BMC Cancer; 2013 Feb; 13():53. PubMed ID: 23374877
[TBL] [Abstract][Full Text] [Related]
26. Updating the natural history of human papillomavirus and anogenital cancers.
Moscicki AB; Schiffman M; Burchell A; Albero G; Giuliano AR; Goodman MT; Kjaer SK; Palefsky J
Vaccine; 2012 Nov; 30 Suppl 5(0 5):F24-33. PubMed ID: 23199964
[TBL] [Abstract][Full Text] [Related]
27. Association of cytokeratin 17 expression with differentiation in oral squamous cell carcinoma.
Kitamura R; Toyoshima T; Tanaka H; Kawano S; Kiyosue T; Matsubara R; Goto Y; Hirano M; Oobu K; Nakamura S
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1299-310. PubMed ID: 22466643
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical assessment of p16, COX-2 and EGFR in HPV-positive cervical squamous intraepithelial lesions.
Balan R; Simion N; Giuşcă SE; Grigoraş A; Gheucă-Solovăstru L; Gheorghiţă V; Amălinei C; Căruntu ID
Rom J Morphol Embryol; 2011; 52(4):1187-94. PubMed ID: 22203921
[TBL] [Abstract][Full Text] [Related]
29. Detection and genotyping of human papilloma virus in cervical cancer specimens from Saudi patients.
Al-Badawi IA; Al-Suwaine A; Al-Aker M; Asaad L; Alaidan A; Tulbah A; Fe Bohol M; Munkarah AR
Int J Gynecol Cancer; 2011 Jul; 21(5):907-10. PubMed ID: 21697680
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and distribution of high risk human papillomavirus (HPV) Types 16 and 18 in Carcinoma of cervix, saliva of patients with oral squamous cell carcinoma and in the general population in Karnataka, India.
Kulkarni SS; Kulkarni SS; Vastrad PP; Kulkarni BB; Markande AR; Kadakol GS; Hiremath SV; Kaliwal S; Patil BR; Gai PB
Asian Pac J Cancer Prev; 2011; 12(3):645-8. PubMed ID: 21627358
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and genotypes' distribution of human papillomavirus in invasive cervical cancer in Saudi Arabia.
Alsbeih G; Ahmed R; Al-Harbi N; Venturina LA; Tulbah A; Balaraj K
Gynecol Oncol; 2011 Jun; 121(3):522-6. PubMed ID: 21353296
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of p16 and ProExC immunostaining in the detection of high-grade cervical intraepithelial neoplasia and cervical carcinoma.
Guo M; Baruch AC; Silva EG; Jan YJ; Lin E; Sneige N; Deavers MT
Am J Clin Pathol; 2011 Feb; 135(2):212-20. PubMed ID: 21228361
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic value of p16INK4A, Ki-67, and human papillomavirus L1 capsid protein immunochemical staining on cell blocks from residual liquid-based gynecologic cytology specimens.
Yu L; Wang L; Zhong J; Chen S
Cancer Cytopathol; 2010 Feb; 118(1):47-55. PubMed ID: 20069634
[TBL] [Abstract][Full Text] [Related]
35. p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis.
Tsoumpou I; Arbyn M; Kyrgiou M; Wentzensen N; Koliopoulos G; Martin-Hirsch P; Malamou-Mitsi V; Paraskevaidis E
Cancer Treat Rev; 2009 May; 35(3):210-20. PubMed ID: 19261387
[TBL] [Abstract][Full Text] [Related]
36. Coordinate expression of cytokeratin 8 and cytokeratin 17 immunohistochemical staining in cervical intraepithelial neoplasia and cervical squamous cell carcinoma: an immunohistochemical analysis and review of the literature.
Ikeda K; Tate G; Suzuki T; Mitsuya T
Gynecol Oncol; 2008 Mar; 108(3):598-602. PubMed ID: 18191996
[TBL] [Abstract][Full Text] [Related]
37. High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma.
Ressler S; Scheiden R; Dreier K; Laich A; Müller-Holzner E; Pircher H; Morandell D; Stein I; Viertler HP; Santer FR; Widschwendter A; Even J; Jansen-Dürr P; Capesius C; Zwerschke W
Clin Cancer Res; 2007 Dec; 13(23):7067-72. PubMed ID: 18056184
[TBL] [Abstract][Full Text] [Related]
38. The possible role of cell cycle regulators in multistep process of HPV-associated cervical carcinoma.
Bahnassy AA; Zekri AR; Saleh M; Lotayef M; Moneir M; Shawki O
BMC Clin Pathol; 2007 May; 7():4. PubMed ID: 17521451
[TBL] [Abstract][Full Text] [Related]
39. p16INK4a immunoexpression: surrogate marker of high-risk HPV and high-grade cervical intraepithelial neoplasia.
Kalof AN; Cooper K
Adv Anat Pathol; 2006 Jul; 13(4):190-4. PubMed ID: 16858153
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of p16 INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia.
Ishikawa M; Fujii T; Saito M; Nindl I; Ono A; Kubushiro K; Tsukazaki K; Mukai M; Nozawa S
Int J Gynecol Cancer; 2006; 16(1):347-53. PubMed ID: 16445657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
